Etv5 safeguards trophoblast stem cells differentiation from mouse EPSCs by regulating fibroblast growth factor receptor 2.
Kui ZhuYuan LiuChen FanMengyao ZhangHongxia CaoXin HeNa LiDianfeng ChuFang LiMin ZouJinlian HuaHuayan WangYan WangGencheng FanShiqiang ZhangPublished in: Molecular biology reports (2020)
Previous studies have demonstrated that transcription factor Etv5 plays an important role in the segregation between epiblast and primitive endoderm at the second fate decision of early embryo. However, it remains elusive whether Etv5 functions in the segregation between inner cell mass and trophectoderm at the first cell fate decision. In this study, we firstly generated Etv5 knockout mouse embryonic stem cells (mESCs) by CRISPR/Cas9, then converted them into extended potential stem cells (EPSCs) by culturing the cells in small molecule cocktail medium LCDM (LIF, CHIR99021, (S)-(+)-dimethindene maleate, minocycline hydrochloride), and finally investigated their differentiation efficiency of trophoblast stem cells (TSCs). The results showed that Etv5 knockout significantly decreased the efficiency of TSCs (CDX2+) differentiated from EPSCs. In addition, Etv5 knockout resulted in higher incidence of the differentiated cells with tetraploid and octoploid than that from wild type. Mechanistically, Etv5 was activated by extracellular-signal-regulated kinase (ERK) signaling pathway; in turn, Etv5 had a positive feedback on the expression of fibroblast growth factor receptor 2 (FGFR2) which lies upstream of ERK. Etv5 knockout decreased the expression of FGFR2, whose binding with fibroblast growth factor 4 was essentially needed for TSCs differentiation. Collectively, the findings in this study suggest that Etv5 is required to safeguard the TSCs differentiation by regulating FGFR2 and provide new clues to understand the specification of trophectoderm in vivo.
Keyphrases
- acute lymphoblastic leukemia
- stem cells
- signaling pathway
- induced apoptosis
- small molecule
- wild type
- transcription factor
- crispr cas
- poor prognosis
- embryonic stem cells
- pi k akt
- cell fate
- cell therapy
- cell proliferation
- cell cycle arrest
- genome editing
- risk factors
- mass spectrometry
- oxidative stress
- endoplasmic reticulum stress
- long non coding rna
- pregnant women
- risk assessment
- mesenchymal stem cells
- tyrosine kinase
- decision making
- bone marrow
- sensitive detection
- high resolution